Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Comparative Effectiveness: The Next Gatekeeper to Commercial Success

Sep 01 2007

• By Kate Rawson

Related Content

An Eye for an Eye: Lucentis and the New Pharmaceutical Value System

Jun 01 2007

The DERP-icenter of the Evidence-Based Revolution

May 01 2007

Is Comparative Effectiveness Antithetical to Personalized Medicine?

Sep 01 2007

The Congressional Budget Office's Case for Comparative Effectiveness

Jul 01 2007

Lessons From ALLHAT and CATIE

Sep 01 2007

With Enemies Like These: Will the Democrats Make Part D More Pharma Friendly?

Sep 01 2007

CATIE: Learning to Live With large Comparative Trials

Dec 01 2005

Fashionably Early: When to Make Your Case to CMS

Feb 01 2006

Nervous Times for NDA Sponsors: The New Reality of FDA Drug Reviews

Apr 01 2007

Related Companies

Genentech, Inc.

Dow Chemical Co.

Merck & Co., Inc.

Additional Topics

Strategy Clinical Trials Business Strategies Regulation Reimbursement Government Payers

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.